Nanostructured lipid carriers based mRNA vaccine leads to a T cell–inflamed tumour microenvironment favourable for improving PD-1/PD-L1 blocking therapy and long-term immunity in a cold tumour modelResearch in context by Carole Fournier, Marion Mercey-Ressejac, Valentin Derangère, Amal Al Kadi, David Rageot, Christine Charrat, Alexis Leroy, Julien Vollaire, Véronique Josserand, Marie Escudé, Séverine Escaich, François Ghiringhelli, Thomas Decaens, Fabrice P. Navarro, Evelyne Jouvin-Marche, Patrice N. Marche

Subjects: “…mRNA vaccine…”
Get full text

A HABA dye-based colorimetric assay to detect unoccupied biotin binding sites in an avidin-containing fusion protein by Sonia Mukherjee, Pierre Leblanc, Mark C Poznansky, Ann E Sluder

Subjects: Get full text

CLINICAL IMMUNOLOGY AND ALLERGOLOGY AS AN IMPORTANT COMPONENT OF CONTINUOUS MEDICAL EDUCATION OF DOCTORS by Anna Havrylyuk, Svitlana Zubchenko, Valentyna Chopyak

Subjects: Get full text

Autoimmune/autoinflammatory syndrome induced by adjuvants: what is it and why the controversy? by Sajal Ajmani

Subjects: Get full text

Immunogenic characteristics of <i>Avibacterium paragallinаrum</i> (serogroup B) isolates and strains by M. S. Firsova, V. A. Yevgrafova, A. V. Potekhin, R. V. Yashin, O. V. Pruntova, V. S. Russaleyev

Subjects: Get full text

Disparities in the uptake of HPV-related cancer prevention strategies among women by HIV status in Puerto Rico by Marievelisse Soto-Salgado, Melisa Ramos-Sepúlveda, Jeslie M. Ramos-Cartagena, Maribel Tirado-Gómez, Humberto M. Guiot, Cristina Muñoz-Masso, Lorena González-Sepúlveda, Ana Patricia Ortiz

Subjects: Get full text

Effects of different educational interventions on cervical cancer knowledge and human papillomavirus vaccination uptake among young women in Japan: Preliminary results of a cluster randomized controlled trial by Yuko Takahashi, Yukifumi Sasamori, Risa Higuchi, Asumi Kaku, Tomoo Kumagai, Saya Watanabe, Miki Nishizawa, Kazuki Takasaki, Haruka Nishida, Takayuki Ichinose, Mana Hirano, Yuko Miyagawa, Haruko Hiraike, Koichiro Kido, Hirono Ishikawa, Kazunori Nagasaka

Get full text

Strategies and resources used by public health units to encourage COVID-19 vaccination among priority groups: a behavioural science-informed review of three urban centres in Canada by Tori Langmuir, Mackenzie Wilson, Nicola McCleary, Andrea M. Patey, Karim Mekki, Hanan Ghazal, Elizabeth Estey Noad, Judy Buchan, Vinita Dubey, Jana Galley, Emily Gibson, Guillaume Fontaine, Maureen Smith, Amjad Alghamyan, Kimberly Thompson, Jacob Crawshaw, Jeremy M. Grimshaw, Trevor Arnason, Jamie Brehaut, Susan Michie, Melissa Brouwers, Justin Presseau

Subjects: “…COVID-19 vaccine…”
Get full text

Assessment of Child Immunization Coverage and Associated Factors with Full Vaccination among Children Aged 12–23 Months at Mizan Aman Town, Bench Maji Zone, Southwest Ethiopia by Asrat Meleko, Mesfin Geremew, Frehiwot Birhanu

“…A total of 322 mothers/caretakers were interviewed. Based on vaccination card and mothers/caretakers’ recall, 295 (91.6%) of the children took at least a single dose of vaccine. …”
Get full text

Distinct response patterns of endothelial markers to the BNT162b2 mRNA COVID-19 booster vaccine are associated with the spike-specific IgG antibody production by Beatriz Castro-Robles, Francisco J. Cimas, Francisco J. Cimas, Lourdes Arias-Salazar, Jesús Ontañón, Julia Lozano, Susana López-López, Fernando Andrés-Pretel, María Ángeles Requena-Calleja, Antonio Mas, Antonio Mas, Antonio Mas, Gemma Serrano-Heras, Tomás Segura, Tomás Segura, Javier Solera

Subjects: “…mRNA COVID-19 vaccines…”
Get full text

Prevalence and Predictors of COVID-19 Vaccine Hesitancy among Health Care Workers in Tertiary Health Care Institutions in a Developing Country: A Cross-Sectional Analytical Study by Chinedu Anthony Iwu, Pius Ositadinma, Victor Chibiko, Ugochukwu Madubueze, Kenechi Uwakwe, Uche Oluoha

“…Result. The prevalence of vaccine hesitancy was 35.4%. HCWs of the Pentecostal faith (aOR: 2.52) and males (aOR: 2.72) were significantly more likely to be COVID-19 vaccine hesitant. …”
Get full text

Development of a differentiating of infected from vaccinated animal (DIVA) ELISA to detect antibodies against Senecavirus A in pigs using two expression systems of non-structural proteins by Parin Watcharavongtip, Patumporn Jermsutjarit, Angkana Tantituvanont, Dachrit Nilubol

“…They can be valuable tools for sero-surveillance and for evaluating immunity status tests to support and approve vaccination programs for pig herds in the future.…”
Get full text

A cGAMP‐Containing Hydrogel for Prolonged SARS‐CoV‐2 Receptor‐Binding Domain Subunit Vaccine Exposure Induces a Broad and Potent Humoral Response by Volker Böhnert, Emily C. Gale, Lauren J. Lahey, Jerry Yan, Abigail E. Powell, Ben S. Ou, Jacqueline A. Carozza, Lingyin Li, Eric A. Appel

Subjects: Get full text

Impact of vaccination against SARS-CoV-2 on mortality risk, ICU admission rate, and hospitalization length in hospitalized COVID-19 patients: a cross-sectional study by Behnam Maleki, Amir M. Sadeghian, Mitra Ranjbar

Subjects: Get full text

A population-based study on the burden of hospitalized pediatric pneumococcal disease in Taiwan before and after the introduction of 13-valent pneumococcal conjugate vaccine into the childhood immunization program in 2015 by Ting-An Yen, Jhong-Lin Wu, Chi-Chuan Wang, Ling-Ya Huang, See-Hwee Yeo, Dony Patel, Cindy Thiow Koon Lim, Hung-Wei Lin, Eriko Yamada, Isaya Sukarom

Subjects: “…Pneumococcal conjugate vaccine…”
Get full text

Parenterally Administered Norovirus GII.4 Virus-Like Particle Vaccine Formulated with Aluminum Hydroxide or Monophosphoryl Lipid A Adjuvants Induces Systemic but Not Mucosal Immune Responses in Mice by Suvi Heinimäki, Maria Malm, Timo Vesikari, Vesna Blazevic

“…Norovirus (NoV) is a main cause of acute gastroenteritis across all ages worldwide. NoV vaccine candidates currently in clinical trials are based on noninfectious highly immunogenic virus-like particles (VLPs) delivered intramuscularly (IM). …”
Get full text

Immunobiological properties of inactivated anti-highly pathogenic avian influenza vaccines based on antigens of А/Н5N1 avian influenza virus strains of different virulence by S. V. Frolov, I. A. Chvala, N. V. Moroz, V. Yu. Kulakov, V. Yu. Sosipatorova, D. B. Andreychuk

Subjects: “…inactivated vaccine…”
Get full text

Adjuvant-free, self−assembling ferritin nanoparticle vaccine coupled with influenza virus hemagglutinin protein carrying M1 and PADRE epitopes elicits cross-protective immune responses by Yongqiang Zhao, Shuangshuang Guo, Jia Liu, Yating Wang, Bo Wang, Chun Peng, Enqi Du, Enqi Du, Enqi Du

Subjects: Get full text

Inflammatory rheumatic diseases with onset after SARS-CoV-2 infection or COVID-19 vaccination: a report of 267 cases from the COVID-19 and ASD group by Laura Massaro, Annamaria Iagnocco, Florenzo Iannone, Corrado Campochiaro, Maria De Santis, Ilaria Cavazzana, Piero Ruscitti, Roberto Giacomelli, Rosario Foti, Lorenzo Dagna, Giovanna Cuomo, Giacomo De Luca, Francesco Caso, Ilenia Di Cola, Clodoveo Ferri, Vincenzo Raimondo, Francesco Ursini, Veronica Brusi, Giuseppe Varcasia, Roberta Pellegrini, Domenico Olivo, Giuseppe Murdaca, Carlo Selmi, Olga Addimanda, Erika Pigatto, Francesca Francioso, Rossella De Angelis, Jacopo Ciaffi, Luana Mancarella, Marcella Visentini, Francesca Motta, Virginia Caira, Alberto Lo Gullo, Caterina Naclerio, Elena Marchetti, Sebastiano Lorusso, Jessica Luppino, Roberta Foti, Massimo Reta

“…Objectives To better define the spectrum of new-onset post-COVID-19 and post-COVID-19 vaccine inflammatory rheumatic diseases (IRD) from a large multicentric observational study.Methods Consecutive cases of IRD encountered during a 12-month period and satisfying one of the following inclusion criteria: (a) onset of the rheumatic manifestations within 4 weeks from SARS-CoV-2 infection or (b) onset of the rheumatic manifestations within 4 weeks from the administration of one of the COVID-19 vaccines ws recruited.Results The final analysis cohort comprised 267 patients, of which 122 (45.2%) in the post-COVID-19 and 145 (54.8%) in the postvaccine cohort. …”
Get full text

A Model H5N2 Vaccine Strain for Dual Protection Against H5N1 and H9N2 Avian Influenza Viruses by Jin-Ha Song, Seung-Eun Son, Ho-Won Kim, Se-Hee An, Chung-Young Lee, Hyuk-Joon Kwon, Kang-Seuk Choi

“…Vaccines…”
Get full text